Daptomycin-Induced Pulmonary Toxicity: A Case Series.
| Autor: | Patel YI; Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, USA., Natarajan S; Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, USA., Ramakrishna S; Pulmonary and Critical Care Medicine, Geisinger Commonwealth School of Medicine, Scranton, USA., Ochieng P; Pulmonary and Critical Care Medicine, Geisinger Commonwealth School of Medicine, Scranton, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 May 28; Vol. 15 (5), pp. e39613. Date of Electronic Publication: 2023 May 28 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.39613 |
| Abstrakt: | Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP). Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Patel et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|